Patents by Inventor Thomas Veje Lundgaard

Thomas Veje Lundgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-GLYCOSYLATED HUMAN GROWTH HORMONE WITH PROLONGED CIRCULATORY HALF-LIFE
    Publication number: 20110118183
    Abstract: The present invention relates to novel human growth hormone (hGH) variant(s) with one or more N-glycans. The hGH variants of the invention comprises an amino acid sequence which includes at least one N-glycosylation motif (N-X-S/T) arising from one or more mutations not present in the wild type hGH. The hGH variants of the invention have a prolonged circulatory half-life and thus can be effectively used as a protein therapeutic for disease states that will benefit from increased levels of hGH. The process of obtaining the hGH variants is also encompassed by the invention.
    Type: Application
    Filed: June 26, 2009
    Publication date: May 19, 2011
    Applicant: Novo Nordisk Health Care AG
    Inventors: Gert Bolt, Claus Kristensen, Esper Boel, Thomas Veje Lundgaard